<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34532828</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>08</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2240-2993</ISSN><JournalIssue CitedMedium="Internet"><Volume>122</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Acta neurologica Belgica</Title><ISOAbbreviation>Acta Neurol Belg</ISOAbbreviation></Journal><ArticleTitle>Communicating the diagnosis: a survey of patients with amyotrophic lateral sclerosis and their families in Japan.</ArticleTitle><Pagination><StartPage>471</StartPage><EndPage>478</EndPage><MedlinePgn>471-478</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s13760-021-01801-3</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To assess the needs of patients with amyotrophic lateral sclerosis (ALS) and their families when being communicated the diagnosis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We held a nationwide webinar in September 2020, titled "ALS Caf&#xe9;", and distributed a self-report questionnaire to participants.</AbstractText><AbstractText Label="PATIENTS" NlmCategory="METHODS">This cross-sectional study included 56 respondents (patients, n&#x2009;=&#x2009;32; family members, n&#x2009;=&#x2009;24).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 56 respondents, 47 (84%) reported being anxious when they were communicated their diagnosis. The average time allocated for communicating the diagnosis was 36.3&#x2009;&#xb1;&#x2009;25.6&#xa0;min, and 30% of respondents believed that insufficient time was allocated. Nearly half of the respondents were communicated their diagnosis by one physician, and 57% of the respondents received their diagnosis in one session. Approximately 80% of respondents received information about ventilators when they were being communicated their diagnosis, but most patients did not want to receive this information at that time. The anxious group tended to answer that the time to communicate the diagnosis was short. Meanwhile, all respondents in the mildly anxious group were provided with one or more information about the supportive contents along with the diagnosis. Moreover, in Japan, many patients with ALS and their families desire the legalization of euthanasia, which might affect decision-making.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study shows that a longer amount of time spent communicating the diagnosis and provision of descriptions needed by patients and their families are important. This can help clinicians understand what the patient requires while being communicated their diagnosis.</AbstractText><CopyrightInformation>&#xa9; 2021. Belgian Neurological Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hirayama</LastName><ForeName>Takehisa</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-3056-3176</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Toho University Faculty of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Izumi</LastName><ForeName>Yuishin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakayama</LastName><ForeName>Yuki</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Unit for Intractable Disease Nursing Care, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shibukawa</LastName><ForeName>Mari</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Toho University Faculty of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ebihara</LastName><ForeName>Satoru</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation Medicine, Toho University Faculty of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kano</LastName><ForeName>Osamu</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Neurology, Toho University Faculty of Medicine, Tokyo, Japan. osamu.kano@med.toho-u.ac.jp.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Acta Neurol Belg</MedlineTA><NlmUniqueID>0247035</NlmUniqueID><ISSNLinking>0300-9009</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007564" MajorTopicYN="N" Type="Geographic">Japan</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Communicating a diagnosis</Keyword><Keyword MajorTopicYN="N">Euthanasia</Keyword><Keyword MajorTopicYN="N">Tracheostomy and invasive ventilator</Keyword><Keyword MajorTopicYN="N">Webinar</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>17</Day><Hour>7</Hour><Minute>27</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34532828</ArticleId><ArticleId IdType="doi">10.1007/s13760-021-01801-3</ArticleId><ArticleId IdType="pii">10.1007/s13760-021-01801-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mitsumoto H, Chad DA, Pioro EP (1998) Amyotrophic lateral sclerosis. F.A. Davis Company, Philadelphia</Citation></Reference><Reference><Citation>Aoun SM, Breen LJ, Edis R et al (2016) Breaking the news of a diagnosis of motor neurone disease: a national survey of neurologists&#x2019; perspectives. J Neurol Sci 367:368&#x2013;374. https://doi.org/10.1016/j.jns.2016.06.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2016.06.033</ArticleId><ArticleId IdType="pubmed">27423623</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoun SM, Breen LJ, Howting D et al (2016) Receiving the news of a diagnosis of motor neurone disease: what does it take to make it better? Amyotroph Lateral Scler Frontotemporal Degener 17(3&#x2013;4):168&#x2013;178. https://doi.org/10.3109/21678421.2015.1111907</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1111907</ArticleId><ArticleId IdType="pubmed">26609553</ArticleId></ArticleIdList></Reference><Reference><Citation>Ley P (1998) Communication with patients: improving communication, satisfaction and compliance. Croon Helm, London</Citation></Reference><Reference><Citation>Silverstein MD, Stocking CB, Antel JP, Beckwith J, Roos RP, Siegler M (1991) Amyotrophic lateral sclerosis and life-sustaining therapy: patients&#x2019; desire for information, participation in decision making, and life-sustaining therapy. Mayo Clin Proc 66:906&#x2013;913. https://doi.org/10.1016/s0025-6196(12)61577-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0025-6196(12)61577-8</ArticleId><ArticleId IdType="pubmed">1921500</ArticleId></ArticleIdList></Reference><Reference><Citation>Baile WF, Buckman R, Lenzi R, Glober G, Beale EA, Kudelka AP (2000) SPIKES&#x2014;a six-step protocol for delivering bad news: application to the patient with cancer. Oncologist 5(4):302&#x2013;311. https://doi.org/10.1634/theoncologist.5-4-302</Citation><ArticleIdList><ArticleId IdType="doi">10.1634/theoncologist.5-4-302</ArticleId><ArticleId IdType="pubmed">10964998</ArticleId><ArticleId IdType="pmc">10964998</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson PM, Abrahams S, Borasio GD et al (2012) EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)&#x2014;revised report of an EFNS task force. Eur J Neurol 19(3):360&#x2013;375. https://doi.org/10.1111/j.1468-1331.2011.03501.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2011.03501.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Vianello A, Concas A (2014) Tracheostomy ventilation in ALS: a Japanese bias. J Neurol Sci 344:3&#x2013;4. https://doi.org/10.1016/j.jns.2014.06.050</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2014.06.050</ArticleId><ArticleId IdType="pubmed">25012483</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanda Y (2013) Investigation of the freely available easy-to-use software &#x2018;EZR&#x2019; for medical statistics. Bone Marrow Transplant 48:452&#x2013;458. https://doi.org/10.1038/bmt.2012.244</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/bmt.2012.244</ArticleId><ArticleId IdType="pubmed">23208313</ArticleId></ArticleIdList></Reference><Reference><Citation>Mccluskey L, Casarett D, Siderof A (2004) Breaking the news: a survey of ALS patients and their caregivers. Amyotroph Lateral Scler Other Motor Neuron Disord 5:131&#x2013;135. https://doi.org/10.1080/14660820410020772</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14660820410020772</ArticleId><ArticleId IdType="pubmed">15512900</ArticleId></ArticleIdList></Reference><Reference><Citation>Borasio GD, Sloan R, Pongratz DE (1998) Breaking the news in amyotrophic lateral sclerosis. J Neurol Sci 160(suppl 1):S127&#x2013;S133. https://doi.org/10.1016/s0022-510x(98)00211-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-510x(98)00211-1</ArticleId><ArticleId IdType="pubmed">9851662</ArticleId></ArticleIdList></Reference><Reference><Citation>Veldink JH, Wokke JHJ, Wal G, Vianney JMB, Berg LH (2002) Euthanasia and physician-assisted suicide among with amyotrophic lateral sclerosis in Netherlands. N Engl J Med 346(21):1638&#x2013;1644. https://doi.org/10.1056/NEJMsa012739</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMsa012739</ArticleId><ArticleId IdType="pubmed">12023997</ArticleId></ArticleIdList></Reference><Reference><Citation>Maessen M, Veldink JH, Onwuteaka-Philipsen BD et al (2014) Euthanasia and physician-assisted suicide in amyotrophic lateral sclerosis: a prospective study. J Neurol 261:1894&#x2013;1901. https://doi.org/10.1007/s00415-014-7424-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-014-7424-6</ArticleId><ArticleId IdType="pubmed">25022937</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>